Skip to main content

stock

ADIL · ADIAL PHARMACEUTICALS, INC.

What ADIAL PHARMACEUTICALS, INC. reports to the SEC, read from its filings.

Open in the app

Price

The live ADIL price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on ADIL.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
2,625,890 as of 2026-08-12 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
—
ROA
-27426346.1%

Health

Current ratio
5.6x
Debt/equity
—

Deep value

NCAV
-$88,000
NCAV per share
-$0.03
Price/NCAV
Locked
NNWC
-$221,000
NNWC per share
-$0.08
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenue (not reported by this company)Gross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$52.02M-$51.99M
10-Q filed 2026-08-14
2026-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$2.00M-$2.02M
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$1.89M-$7.98T
DEF 14A filed 2026-08-24
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$1.76M-$1.79M
10-Q filed 2025-11-13
2025-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$1.88M-$1.96M
10-Q filed 2026-08-14
2025-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$2.27M-$2.23M
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$1.94M-$13.20T
DEF 14A filed 2026-08-24
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$2.21M-$2.19M
10-Q filed 2025-11-13
Assets
$29.09M
Equity
-$38.38M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$7.80M-$7.98T—
2024-12-31—-$8.28M-$13.20T—
2023-12-31—-$6.89M-$5.12T—
2022-12-31—-$10.86M-$12.73M—
2021-12-31—-$19.29M-$19.42M-$12.01M
2020-12-31—-$10.93M-$10.89M—
2019-12-31—-$8.24M-$8.59M—
2018-12-31—-$6.99M-$11.63M—
2017-12-31—-$995,286-$1.14M—

Company filings

since Fri Aug 28 · 1 offering filing in 12 months · since Fri Dec 19

events

  • Other event

    Other event
    Oct 28-K
  • Executive or director change, Shareholder vote results

    Executive or director changeShareholder vote results
    Sep 188-K
  • Material agreement, Other event

    Material agreementOther event
    Sep 168-K
  • Unregistered share sale

    Unregistered share sale
    Aug 258-K
  • Listing standard notice

    Listing standard notice
    Aug 218-K
  • Results

    Results
    Aug 178-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Coastlands Capital LP

    10% owner

    Buy$8,691

    Jul 16, 5:08 PM ET

  • Coastlands Capital LP

    10% owner

    Buy$32,638

    Jul 13, 10:30 AM ET

All insider trades for ADIL

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named ADIL, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about ADIL.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about ADIL.

nakagai

Signals on ADIL come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the ADIL board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

ADIAL PHARMACEUTICALS, INC. (ADIL): SEC filings, financials and insider trades · Nakagai